March 25, 2020 / 11:29 AM / 13 days ago

BRIEF-Cara Therapeutics Reports Clinical Updates

March 25 (Reuters) - Cara Therapeutics Inc:

* CARA THERAPEUTICS REPORTS CLINICAL UPDATES

* CARA THERAPEUTICS INC - TIMELINE TO SUBMIT KORSUVA INJECTION NEW DRUG APPLICATION TO FDA IN SECOND HALF OF 2020 REMAINS UNCHANGED

* CARA THERAPEUTICS INC - ALSO CURRENTLY EVALUATING ORAL KORSUVA IN TWO ONGOING PHASE 2 TRIALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below